Skip to main content

Table 4 Multivariate analysis for overall survival

From: The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis

Characteristics

HR (95 % CI)

p-value

Age (≥65 vs <65)

9.749 (3.404–27.919)

<0.001

Sex (female vs male)

3.070 (1.260–7.478)

0.014

T stage (T4 vs T1-3)

3.511 (1.484–8.307)

0.004

Use of Cetuximab at 1st post-operative chemotherapy (Yes vs No)

1.185 (0.235–5.979)

0.837

  1. Abbreviations: CI confidence interval A.A amino acid; HR, hazard ratio